Date: 2015-06-18
Type of information: Nomination
Compound:
Company: ITeos Therapeutics (Belgium)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On June 18, 2015, iTeos Therapeutics announced the appointment of Bruno Montanari, PharmD, to the company’s board of directors. Dr. Montanari adds further depth to iTeos’ board by bringing knowledge and experience gained through a long investment career in the life sciences sector. Dr. Montanari graduated as a PharmD from Université René Descartes (Paris V) and holds a Masters degree from Ecole des Hautes Etudes Commerciales (HEC, Paris). Since 1999, he held various positions in the healthcare groups of Deutsche Bank and Merrill Lynch investment banking divisions, to later embrace venture capital with CDP Capital and Atlas Venture. He currently is a Director in the venture team of Omnes Capital (formerly known as Crédit Agricole Private Equity), which he joined in 2010.
Financial terms:
Latest news:
